Zivo Bioscience, Inc. (ZIVO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 35K 70K 105K Q4 '23: 11.8K Q1 '24: 35.7K Q2 '24: 0 Q3 '24: 31.5K Q4 '24: 90K Q1 '25: 0 Q2 '25: 53.4K Q3 '25: 65.6K Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Gross Profit Quarterly

0 10K 20K 30K Q4 '23: 4.1K Q1 '24: 12.5K Q2 '24: 0 Q3 '24: 9.4K Q4 '24: 27K Q1 '25: 0 Q2 '25: 17.9K Q3 '25: 21.3K Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q4 '23: -1.9M Q1 '24: -1.3M Q2 '24: -8.2M Q3 '24: -2.3M Q4 '24: -1.6M Q1 '25: -4.2M Q2 '25: -1.6M Q3 '25: -1M Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Net Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q4 '23: -1.9M Q1 '24: -1.3M Q2 '24: -8.2M Q3 '24: -2.3M Q4 '24: -1.6M Q1 '25: -4.2M Q2 '25: -1.6M Q3 '25: -1M Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Cost of Revenue Quarterly

0 25K 50K 75K Q4 '23: 7.7K Q1 '24: 23.2K Q2 '24: 0 Q3 '24: 22.1K Q4 '24: 63K Q1 '25: 0 Q2 '25: 35.5K Q3 '25: 44.3K Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating Cash Flow Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q4 '23: -715.7K Q1 '24: -1.7M Q2 '24: -623.7K Q3 '24: -1.1M Q4 '24: -905.7K Q1 '25: -1.4M Q2 '25: -476.4K Q3 '25: -266.6K Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

Free Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q3 '11: -254.4K Q4 '11: -523.7K Q1 '12: -534.2K Q1 '12: -534.2K Q2 '12: -417.3K Q3 '12: -468.6K Q4 '12: -356.7K Q3 '13: -783.5K Q3 '11 Q4 '11 Q1 '12 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q3 '13

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '15: 129.6M Q2 '15: 130.4M Q1 '24: 2.7M Q2 '24: 3M Q3 '24: 3.4M Q1 '25: 3.8M Q2 '25: 3.8M Q3 '25: 3.8M Q1 '15 Q2 '15 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q4 '20: -0.02 Q1 '21: -0.02 Q2 '21: -0.07 Q3 '21: 0.41 Q4 '24: -4.28 Q1 '25: -4.93 Q2 '25: -2.58 Q3 '25: -2.18 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '24 Q1 '25 Q2 '25 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.